Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comorbidity and Comedication During Prescription of ALNA® (Tamsulosin) for Patients With BPH (Benign Prostatic Hyperplasia)

NCT02245503 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02245503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02245503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comorbidity and Comedication During Prescription of ALNA® (Tamsulosin) for Patients With BPH (Benign Prostatic Hyperplasia)
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
May 31, 2003
Completion date
Not reported
Enrollment
7,391 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic hyperplasia